LMO7 antibody (AA 616-644)
Quick Overview for LMO7 antibody (AA 616-644) (ABIN1881503)
Target
See all LMO7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 616-644
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This LMO7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 616-644 amino acids from the Central region of human LMO7.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Expiry Date
- 6 months
-
-
- LMO7 (LIM Domain 7 (LMO7))
-
Alternative Name
- LMO7
-
Background
- LMO7 contains a calponin homology (CH) domain, a PDZ domain, and a LIM domain. An F-box (FBX) domain is present in alternative splice variants. Members of the LIM protein family carry the LIM domain, a unique cysteine-rich zinc-binding domain. Members of the FBX protein family are involved in protein-protein interactions. LMO7 may be involved in protein-protein interactions. Multiple alternative splice variants have been described but their full-length sequences have not been determined.
-
Molecular Weight
- 192696
-
NCBI Accession
- NP_005349, NP_056667
-
UniProt
- Q8WWI1
Target
-